These days, cancer is thought to be more than just one illness, with several complex
subtypes that require different screening approaches. These subtypes can be distinguished …

Owing to their excellent multiplexing ability, high sensitivity, and large dynamic range,
immunoassays using surface-enhanced Raman scattering (SERS) as the readout signal …

Precision medicine in the clinical management of cancer may be achieved through the
diagnostic platform called “liquid biopsy”. This method utilizes the detection of biomarkers in …

Cell-free DNA (cfDNA) refers to short fragments of acellular nucleic acids detectable in
almost all body fluids, including blood, and is involved in various physiological and …

Surface-enhanced Raman spectroscopy, due to its high sensitivity, unique vibrational
fingerprint identification of molecules and easy operation, has been extensively applied in …

Liquid biopsy has emerged as a promising non-invasive strategy for cancer diagnosis,
enabling the detection of various circulating biomarkers, including circulating tumor cells …

In this review, we report the recent advances of SERS in fungi, bacteria, and viruses. Firstly,
we briefly introduce the advantage of SERS over fluorescence on virus identification and …

The clinical management of cancer has evolved in recent years towards more personalized
strategies that require a comprehensive knowledge of the complex molecular features …

For many disease states, positive outcomes are directly linked to early diagnosis, where
therapeutic intervention would be most effective. Recently, trends in disease diagnosis have …

Liquid biopsy for the analysis of circulating cancer biomarkers (CBs) is a major
advancement toward the early detection of cancer. In comparison to tissue biopsy …